Literature DB >> 6115862

Effect of phenobarbital on the development of neoplastic lesions in the liver of cycasin-treated rats.

E Uchida, I Hirono.   

Abstract

The effect of phenobarbital on the development of neoplastic lesions by cycasin was examined in inbred ACI rats. Tumor development in the liver and the kidney was observed in groups of rats treated with a single oral administration of cycasin (100 mg/kg body weight) and maintained on either a control diet or one supplemented with 0.05% phenobarbital. The feeding of phenobarbital diet after the application of cycasin significantly increased the incidence of liver tumors in female rats, but not in male rats. On the other hand, the administration of phenobarbital did not affect the incidence of kidney tumors in either sex. In addition, many large gamma-glutamyltranspeptidase (GGT)-positive foci, which were thought to be preneoplastic lesions, developed in the liver of rats treated with cycasin and then phenobarbital, whereas a small number of tiny foci were seen in rats treated with cycasin alone. Long-term feeding of the 0.05% phenobarbital diet without treatment of cycasin induced many GGT-positive foci which, however, were small-sized. These data indicated phenobarbital to possess a tumor-promoting effect in terms of induction of neoplastic lesions in the liver but not in the kidney.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6115862     DOI: 10.1007/bf00410683

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  24 in total

1.  Enhancement of azo-dye hepatocarcinogenesis with dietary phenobarbital in rats.

Authors:  T Kitagawa; H Sugano
Journal:  Gan       Date:  1977-04

2.  Report of a workshop on classification of specific hepatocellular lesions in rats.

Authors:  R A Squire; M H Levitt
Journal:  Cancer Res       Date:  1975-11       Impact factor: 12.701

3.  The stability of events in the natural history of neoplasia.

Authors:  H C Pitot
Journal:  Am J Pathol       Date:  1977-12       Impact factor: 4.307

4.  Quantitative histochemical and autoradiographic studies of hepatocarcinogenesis in rats fed 2-acetylaminofluorene followed by phenobarbital.

Authors:  T D Pugh; S Goldfarb
Journal:  Cancer Res       Date:  1978-12       Impact factor: 12.701

5.  The natural history of neoplasia. Newer insights into an old problem.

Authors:  H C Pitot
Journal:  Am J Pathol       Date:  1977-11       Impact factor: 4.307

6.  [The effect of phenobarbital and halogenated hydrocarbons on nitrosamine carcinogenesis].

Authors:  W Kunz; G Schaude; C Thomas
Journal:  Z Krebsforsch       Date:  1969

7.  Reduced carcinogenic effects of aflatoxin in rats given phenobarbitone.

Authors:  A E McLean; A Marshall
Journal:  Br J Exp Pathol       Date:  1971-06

8.  n-Nitrosamines in the diet of experimental animals.

Authors:  E A Walker; M Castegnaro; L Griciute
Journal:  Cancer Lett       Date:  1979-03       Impact factor: 8.679

9.  Promotion by dietary phenobarbital of hepatocarcinogenesis by 2-methyl-N,N-dimethyl-4-aminoazobenzene in the rat.

Authors:  T Kitagawa; H C Pitot; E C Miller; J A Miller
Journal:  Cancer Res       Date:  1979-01       Impact factor: 12.701

10.  Spontaneous tumors in ACI/N rats.

Authors:  A Maekawa; S Odashima
Journal:  J Natl Cancer Inst       Date:  1975-12       Impact factor: 13.506

View more
  2 in total

1.  Phenobarbital mediates an epigenetic switch at the constitutive androstane receptor (CAR) target gene Cyp2b10 in the liver of B6C3F1 mice.

Authors:  Harri Lempiäinen; Arne Müller; Sarah Brasa; Soon-Siong Teo; Tim-Christoph Roloff; Laurent Morawiec; Natasa Zamurovic; Axel Vicart; Enrico Funhoff; Philippe Couttet; Dirk Schübeler; Olivier Grenet; Jennifer Marlowe; Jonathan Moggs; Rémi Terranova
Journal:  PLoS One       Date:  2011-03-24       Impact factor: 3.240

2.  A carcinogenic potency database of the standardized results of animal bioassays.

Authors:  L S Gold; C B Sawyer; R Magaw; G M Backman; M de Veciana; R Levinson; N K Hooper; W R Havender; L Bernstein; R Peto
Journal:  Environ Health Perspect       Date:  1984-12       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.